BR112014004829A2 - métodos de ativação da provocação das substâncias de geração de sinal encapsulado e mecanismo utilizando as substâncias de geração de sinal ativado - Google Patents

métodos de ativação da provocação das substâncias de geração de sinal encapsulado e mecanismo utilizando as substâncias de geração de sinal ativado

Info

Publication number
BR112014004829A2
BR112014004829A2 BR112014004829A BR112014004829A BR112014004829A2 BR 112014004829 A2 BR112014004829 A2 BR 112014004829A2 BR 112014004829 A BR112014004829 A BR 112014004829A BR 112014004829 A BR112014004829 A BR 112014004829A BR 112014004829 A2 BR112014004829 A2 BR 112014004829A2
Authority
BR
Brazil
Prior art keywords
signal generation
substances
encapsulated
activation methods
signal
Prior art date
Application number
BR112014004829A
Other languages
English (en)
Inventor
J Richardson Bruce
D Penniman Joseph
Edward Moravick Keith
Campbell Neil
Original Assignee
Supernova Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supernova Diagnostics Inc filed Critical Supernova Diagnostics Inc
Publication of BR112014004829A2 publication Critical patent/BR112014004829A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02—Food
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/18—Water
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G01N33/5304—Reaction vessels, e.g. agglutination plates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances

Abstract

resumo patente de invenção: "métodos de ativação da provocação das substâncias de geração de sinal encapsulado e mecanismo utilizando as substâncias de geração de sinal ativado". os métodos são descritos para a realização de um bioensaio, compreendendo as cápsulas de ativação contendo um precursor de sinal que é hidrolisável a partir de uma forma latente em que substancialmente nenhum sinal é gerado para uma forma em que é capaz de gerar um sinal detectável, a referida ativação compreendendo o tratamento das referidas cápsulas com calor e com um ácido ou uma solução de catalisação de base, a combinação do referido calor e do ph da solução de catalisação sendo tal como para hidrolisar o referido precursor para a forma em que é capaz de gerar um sinal detectável. 20626985v1 1/1 20626985v1
BR112014004829A 2011-08-30 2012-08-30 métodos de ativação da provocação das substâncias de geração de sinal encapsulado e mecanismo utilizando as substâncias de geração de sinal ativado BR112014004829A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/221,600 US8586387B2 (en) 2011-08-30 2011-08-30 Methods of triggering activation of encapsulated signal-generating substances and apparatus utilising activated signal-generating substances
GB201120357A GB2494212B (en) 2011-08-30 2011-11-24 Methods of triggering activation of encapsulated signal-generating substances and apparatus utilising activated signal-generating substances
PCT/GB2012/000690 WO2013030523A1 (en) 2011-08-30 2012-08-30 Methods of triggering activation of encapsulated signal-generating substances and apparatus utilising activated signal-generating substances

Publications (1)

Publication Number Publication Date
BR112014004829A2 true BR112014004829A2 (pt) 2017-04-04

Family

ID=45475721

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014004829A BR112014004829A2 (pt) 2011-08-30 2012-08-30 métodos de ativação da provocação das substâncias de geração de sinal encapsulado e mecanismo utilizando as substâncias de geração de sinal ativado

Country Status (8)

Country Link
US (2) US8586387B2 (pt)
EP (1) EP2751564B1 (pt)
JP (1) JP6121423B2 (pt)
CN (1) CN104024855B (pt)
BR (1) BR112014004829A2 (pt)
ES (1) ES2629929T3 (pt)
GB (3) GB2494212B (pt)
WO (1) WO2013030523A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014226381A1 (de) * 2014-12-18 2016-06-23 Robert Bosch Gmbh Halteeinrichtung, System und Verfahren zur optischen Auslesung eines Teststreifens
JP6530114B1 (ja) * 2018-06-27 2019-06-12 株式会社ニチレイバイオサイエンス メンブランシートのブロッキング方法
JP2020003477A (ja) * 2019-05-09 2020-01-09 株式会社ニチレイバイオサイエンス メンブランシートのブロッキング方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280816A (en) * 1979-10-25 1981-07-28 Nasik Elahi Macroencapsulated immunosorbent assay technique and element therefor
US5344754A (en) * 1993-01-13 1994-09-06 Avocet Medical, Inc. Assay timed by electrical resistance change and test strip
GB9801120D0 (en) * 1998-01-21 1998-03-18 Secr Defence Detection system
US6369893B1 (en) 1998-05-19 2002-04-09 Cepheid Multi-channel optical detection system
DE10042023C2 (de) 2000-08-08 2003-04-10 Biognostic Ag Kapseln, die feste Teilchen signalerzeugender Substanzen einkapseln, und deren Verwendung bei Bioassays zum Nachweis von Zielmolekülen in einer Probe
US7348182B2 (en) * 2000-10-03 2008-03-25 Mirari Biosciences, Inc. Directed microwave chemistry
US7226771B2 (en) * 2002-04-19 2007-06-05 Diversa Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
EP1639093A2 (en) * 2003-06-25 2006-03-29 Georgia Tech Research Corporation Modified molecular beacons
US8029985B2 (en) * 2004-09-01 2011-10-04 Vybion, Inc. Amplified bioassay
MX2007005643A (es) * 2004-11-10 2008-03-13 Cgi Pharmaceuticals Inc Ciertas imidazo [1,2-a] pirazin-8-ilaminas, metodo para su elaboracion y metodo de uso de las mismas.
CN1969917A (zh) * 2005-11-23 2007-05-30 北京奇源益德药物研究所 治疗心脑血管疾病的药物组合物及其制备方法和质控方法
US20080026373A1 (en) * 2006-07-26 2008-01-31 Rodionova Natalia A Assays Based On Light Emission From Analyte Complexes Within A Cassette
WO2008061129A2 (en) * 2006-11-14 2008-05-22 University Of Utah Research Foundation Methods and compositions related to continuous flow thermal gradient pcr
US20090325171A1 (en) * 2008-05-13 2009-12-31 Thomas Hirt Vesicles for use in biosensors
RU2385940C1 (ru) 2008-10-23 2010-04-10 Общество с ограниченной ответственностью "ВИНТЕЛ" Способ определения нуклеиновых кислот методом полимеразно-цепной реакции в режиме реального времени и устройство для его осуществления
NZ596163A (en) * 2009-04-15 2014-01-31 Relia Diagnostic Systems Inc Diagnostic devices and related methods
US20120164128A1 (en) * 2009-05-20 2012-06-28 Academisch Medisch Centrum Means and methods for counteracting polyq expansion disorders
GB2470939A (en) 2009-06-10 2010-12-15 Dna Supernova Ltd Signal amplification microspheres
GB2470962A (en) * 2009-06-12 2010-12-15 Dna Supernova Ltd Amplification medium for use with a solid-phase substrate
JP2011047923A (ja) * 2009-07-27 2011-03-10 Panasonic Corp リポソーム組成物及びその製造方法並びにそれを用いたアナライトの分析方法
BR112012021202B1 (pt) * 2010-02-23 2020-06-09 Genturadx Usa Inc aparelho e métodos para preparação, reação e detecção integradas de amostras

Also Published As

Publication number Publication date
US10139416B2 (en) 2018-11-27
US8586387B2 (en) 2013-11-19
WO2013030523A1 (en) 2013-03-07
GB2509272A (en) 2014-06-25
JP2014525576A (ja) 2014-09-29
GB2494212A (en) 2013-03-06
EP2751564B1 (en) 2017-06-07
GB201120357D0 (en) 2012-01-04
GB201405300D0 (en) 2014-05-07
JP6121423B2 (ja) 2017-04-26
CN104024855A (zh) 2014-09-03
CN104024855B (zh) 2016-02-24
US20130052749A1 (en) 2013-02-28
GB2494212B (en) 2014-02-19
EP2751564A1 (en) 2014-07-09
GB201913483D0 (en) 2019-10-30
US20150104878A1 (en) 2015-04-16
ES2629929T3 (es) 2017-08-16

Similar Documents

Publication Publication Date Title
BR112012027315A8 (pt) polipeptídeo quimérico, composição, molécula de ácido nucleico quimérica, vetor, célula hospedeira, processo de produção de um polipeptídeo, vacina combinada, e, métodos para a indução de uma resposta imunológica e para prevenir ou tratar uma infecção ou doença
BR112013029271A2 (pt) cicatrização de tecido
BR112014010291A2 (pt) composições de lipossoma combinacionais para terapia de câncer
ES2570958T3 (es) Composición para el tratamiento de la fístula
BR112013027119A8 (pt) novos conjugados ligante-droga (adcs) e uso dos mesmos
BR112015012295A8 (pt) Uso de um inibidor de wee1, e, kit para identificar um paciente com câncer
EA201490396A1 (ru) Ингибиторы репликации вирусов гриппа
BR112013020724A2 (pt) vestimenta para uso por um ser vivo, em que a vestimenta é adaptada para uso para fornecer um mapa da atividade elétrica, sistema, método e programa de computador para fornercer um mapa de atividade elétrica do coração de um ser vivo por meio de sinais elétricos do coração obtidos por uma série de eletrodos da superfície que são dispostos sobre uma superfície externa do ser vivo
BR112013019803A2 (pt) método de tratar quelóides ou cicatrizes hipertróficas usando os compostos anti-sentido objetivando fator de desenvolvimento de tecido conjuntivo (ctgf)
BR112013022761B8 (pt) Compostos moduladores heterocíclicos de síntese de lipídios, suas composições e usos
BR112015003742A2 (pt) sistema de montagem de componente de descarga
PE20150203A1 (es) Formulas de testosterona proliposomal
BR112014030835A2 (pt) composição farmacêutica contendo ácido nicotínico e/ou nicotinamida e/ou triptofano para influenciar positivamente a microbiota intestinal
BR112012017994B8 (pt) composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio
BR112015012051A2 (pt) composições e métodos para modulação de expressão de fgfr3
EA201201658A1 (ru) Производные пиперидина и их применение для лечения метаболических нарушений
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
GEP20196969B (en) New therapeutical composition containing apomorphine as active ingredient
BR112014003071A2 (pt) tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical
PE20150764A1 (es) Niclosamida para el tratamiento de tumores solidos
CL2013000310A1 (es) Compuestos derivados de tetrahidrofuranilo disustituidos y sus sales, como antagonistas del receptor b1 de bradiquinina; medicamento que contiene a dichos compuestos; su procedimiento de preparacion, util para el tratamiento agudo o profilactico de dolores agudos, osteoartritis, asma, alergias, entre otras enfermedades.
BR112013030391A2 (pt) derivados de piperidina 3- espirocíclicos como agonistas dos receptores de grelina
BR112014010729A2 (pt) métodos para tratamento de ataques de gota
BR112014004829A2 (pt) métodos de ativação da provocação das substâncias de geração de sinal encapsulado e mecanismo utilizando as substâncias de geração de sinal ativado
BR112015030431A2 (pt) formulação de liberação modificada

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements